DecisionDx-Melanoma Test: A Powerful Tool for Predicting Patient Outcomes

Dr. Abel Jarrell discusses their experience ordering the DecisionDx-Melanoma test, an innovative genomic expression profiling tool that enhances melanoma prognostication. They explain the simplicity of ordering the test, which integrates seamlessly into their electronic medical record system, similar to ordering blood work. Having used DecisionDx for years, they find it invaluable for providing additional reassurance in low-risk cases and identifying hidden risks in seemingly low-risk melanomas. This advanced technology surpasses traditional prognostic methods, like Breslow Depth, by analyzing the biological behavior of melanoma, empowering doctors with insights to improve patient care and monitoring strategies.

Видео DecisionDx-Melanoma Test: A Powerful Tool for Predicting Patient Outcomes канала Castle Biosciences